Stay updated on Semaglutide in Heart Failure, Obesity and Diabetes Clinical Trial
Sign up to get notified when there's something new on the Semaglutide in Heart Failure, Obesity and Diabetes Clinical Trial page.

Latest updates to the Semaglutide in Heart Failure, Obesity and Diabetes Clinical Trial page
- CheckyesterdayChange DetectedRevision label updated from v3.6.5 to v3.6.6 in the page header, indicating a small site maintenance or update to the Record History view.SummaryDifference0.0%

- Check8 days agoNo Change Detected
- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedRecord History now shows the latest site revision as v3.6.5, replacing the previous v3.6.4.SummaryDifference0.0%

- Check36 days agoChange DetectedA new revision label, Revision: v3.6.4, is added to the history, replacing Revision: v3.6.3.SummaryDifference0.0%

- Check58 days agoChange DetectedThe study history now shows a new revision tag v3.6.3 as the latest update. The previous revision v3.6.2 has been removed from the history, reflecting an update to the record's versioning.SummaryDifference0.0%

- Check65 days agoChange DetectedThe page's revision label was updated from v3.6.0 to v3.6.2 in the footer, indicating a deployment/version update. This represents a metadata update related to the site's software version.SummaryDifference0.0%

- Check80 days agoChange DetectedRecruitment status updated to indicate no longer looking for participants. The study record revision was updated from v3.5.5 to v3.6.0.SummaryDifference0.2%

Stay in the know with updates to Semaglutide in Heart Failure, Obesity and Diabetes Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Semaglutide in Heart Failure, Obesity and Diabetes Clinical Trial page.